CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

MYCN overexpression leads to decreased <i>id2a</i> expression in early SCG. by Rodrigo Ibarra-García-Padilla (19697623)

XRP44X decreases tumour burden in a prostate cancer bone metastasis model. by Kostyantyn Semenchenko (112316)

Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair – preliminary data by E.J. Martins (7141313)

“…MMC (n=10) and healthy (n=25) participants of both genders with a mean age of 12.45 years (SD=2.1) were assessed for weight, height, respiratory performance, and isometric peak for shoulder flexors, extensors, abductors, and adductors, using an isokinetic dynamometer. …”

Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection. by Patricia A. Reis (109310)

PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

“…One unit means a decrease in OD₆₂₀ per second. …”

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Mutation (_mut) in the extracellular loop (ECL) 2 leads to decreased <i>cis</i>- and <i>trans</i>-interaction of claudins (Cldns). by Nora Gehne (4357123)

Chronic DCF treatment decreases ATP content (a) and the energy charge (b) of striatal slices by Elisaveta Milusheva (45672)

DOX decreases body mass gain over time in a sub-chronic toxicity model. by Gonçalo C. Pereira (156673)

Pre-treatment of striatal slices by DCF decreases HDA uptake (a) and dopamine content (b) by Elisaveta Milusheva (45672)

AR1’s occurrence gives rise to a decreased preference of ABP for AR2 and 3. by Li-Dong Huang (5659273)

Overexpression of wild-type and mutant ALDH3A1 retards hTCEpi cell proliferation. by Vindhya Koppaka (845151)

“…After 4 d, cells were trypsinized and viable cells were counted using trypan blue exclusion on a hemocytometer. Consecutively, 2.0 x 10⁵ cells were transferred to a new dish and this process repeated for a total of 8 passages, i.e., for 32 d until treated cells showed decreasing cell numbers. …”

BrDU labeling of corneal epithelial cells. by Vindhya Koppaka (845151)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

Characterization of Tet-On hTCEpi-ALDH3A1 cell lines. by Vindhya Koppaka (845151)

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

TIG3 decreases cell survival. by Tiffany M. Scharadin (345930)

“…<b>A</b> TIG3 expression decreases cell number. Values are mean ± SEM, n = 3. …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Sphingomyelinase activity decreases in Alzheimer’s disease. by Alfred N. Fonteh (486638)